Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck CancerJulie E. Bauman, Laura P. Stabile, James Ohr et al.|Cancers|2020Cited by 30
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinomaSuet Kee Loo, Shou‐Jiang Gao, Luping Chen et al.|Cell & Bioscience|2024Cited by 3